THE ELIZABETH TAYLOR AIDS FOUNDATION
TO HOST 2ND ANNUAL NEW YORK DINNER
HONORING LIVE NATION’S ARTHUR FOGEL
Event Supported by Presenting Sponsor Gilead
Sciences
LOS ANGELES, CA— The
Elizabeth Taylor AIDS Foundation (ETAF)announced
today its second annual New York Dinner will take place on
May 8, 2024 at the legendary Rainbow Room on the 65th floor
of Rockefeller Plaza. Generously supported by Presenting
Sponsor Gilead Sciences, Inc., the evening will honor Arthur
Fogel, President, Global Touring and Chairman, Concerts
at Live Nation Entertainment with The Elizabeth Taylor
Commitment to End AIDS Award for his support to end the HIV
epidemic.
The New York Dinner will include an intimate
reception, seated dinner and program, and live performance.
As one of the most visible annual events for ETAF, the
proceeds from the evening will continue the work toward
Elizabeth Taylor’s vision of an AIDS-free world.
“Thank you to the Elizabeth Taylor AIDS
Foundation. I am honored and humbled to receive this award
and I look forward to a great event to support the
Foundation,” said Fogel.
For more information please contact info@etaf.org.
# # #
ABOUT ETAF
Working tirelessly on the AIDS crisis
throughout the 1980s, Elizabeth Taylor established The
Elizabeth Taylor AIDS Foundation (ETAF) in 1991 to carry out
her vision for an AIDS-free world. ETAF works to provide the
direct care needed for people living with and affected by
HIV and AIDS. Emphasizing Elizabeth's voice, commitment, and
concentration on hard-to-reach communities, ETAF's domestic
advocacy initiatives remain a priority. Fighting for
criminalization reform for people living with HIV, ETAF’s
primary advocacy initiative, “HIV Is Not A Crime” fights for
not only the elimination of criminalization, but also stigma
and discrimination. ETAF's programs have also expanded to
ensure that HIV prevention education and access to treatment
are available through domestic and international
initiatives.
ABOUT GILEAD SCIENCES
Gilead Sciences, Inc. is a biopharmaceutical
company that has pursued and achieved breakthroughs in
medicine for more than three decades, with the goal of
creating a healthier world for all people. The company is
committed to advancing innovative medicines to prevent and
treat life-threatening diseases, including HIV, viral
hepatitis, inflammation and cancer. Gilead operates in more
than 35 countries worldwide, with headquarters in Foster
City, California.
|